227 related articles for article (PubMed ID: 26377332)
1. Effects of pelvic organ prolapse ring pessary therapy on intravaginal microbial flora.
Yoshimura K; Morotomi N; Fukuda K; Hachisuga T; Taniguchi H
Int Urogynecol J; 2016 Feb; 27(2):219-27. PubMed ID: 26377332
[TBL] [Abstract][Full Text] [Related]
2. Changes of intravaginal microbiota and inflammation after self-replacement ring pessary therapy compared to continuous ring pessary usage for pelvic organ prolapse.
Yoshimura K; Morotomi N; Fukuda K; Kubo T; Taniguchi H
J Obstet Gynaecol Res; 2020 Jun; 46(6):931-938. PubMed ID: 32189434
[TBL] [Abstract][Full Text] [Related]
3. Bacterial biofilm formation on vaginal ring pessaries used for pelvic organ prolapse.
Gould FG; Carey MP; Plummer EL; Murray GL; Danielewski JA; Tabrizi SN; Garland SM
Int Urogynecol J; 2022 Feb; 33(2):287-295. PubMed ID: 33660005
[TBL] [Abstract][Full Text] [Related]
4. Intravaginal microbial flora by the 16S rRNA gene sequencing.
Yoshimura K; Morotomi N; Fukuda K; Nakano M; Kashimura M; Hachisuga T; Taniguchi H
Am J Obstet Gynecol; 2011 Sep; 205(3):235.e1-9. PubMed ID: 21783170
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of a continuous-use ring-shaped vaginal pessary without support for advanced pelvic organ prolapse in postmenopausal women.
Dueñas JL; Miceli A
Int Urogynecol J; 2018 Nov; 29(11):1629-1636. PubMed ID: 29478114
[TBL] [Abstract][Full Text] [Related]
6. Ring pessary for all pelvic organ prolapse.
Manchana T
Arch Gynecol Obstet; 2011 Aug; 284(2):391-5. PubMed ID: 20848116
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with pessary fitting in women with symptomatic pelvic organ prolapse: A large prospective cohort study.
Ma C; Xu T; Kang J; Zhang Y; Ma Y; Liang S; Zhu L
Neurourol Urodyn; 2020 Nov; 39(8):2238-2245. PubMed ID: 32936968
[TBL] [Abstract][Full Text] [Related]
8. Successful use of ring pessary with support for advanced pelvic organ prolapse.
Ding J; Chen C; Song XC; Zhang L; Deng M; Zhu L
Int Urogynecol J; 2015 Oct; 26(10):1517-23. PubMed ID: 25982787
[TBL] [Abstract][Full Text] [Related]
9. Changes in the Vaginal Microenvironment as Related to Frequency of Pessary Removal.
Fregosi NJ; Hobson DTG; Kinman CL; Gaskins JT; Stewart JR; Meriwether KV
Female Pelvic Med Reconstr Surg; 2018; 24(2):166-171. PubMed ID: 29474292
[TBL] [Abstract][Full Text] [Related]
10. Which factors should be considered in choosing pessary type and size for pelvic organ prolapse patients in a fitting trial?
Ding J; Song XC; Deng M; Zhu L
Int Urogynecol J; 2016 Dec; 27(12):1867-1871. PubMed ID: 27260324
[TBL] [Abstract][Full Text] [Related]
11. Vaginal ring pessary use for pelvic organ prolapse: continuation rates and predictors of continued use.
Manonai J; Sarit-Apirak S; Udomsubpayakul U
Menopause; 2018 Dec; 26(6):665-669. PubMed ID: 30562318
[TBL] [Abstract][Full Text] [Related]
12. Changes in the symptoms and quality of life of women with symptomatic pelvic organ prolapse fitted with a ring with support pessary.
Mao M; Ai F; Zhang Y; Kang J; Liang S; Xu T; Zhu L
Maturitas; 2018 Nov; 117():51-56. PubMed ID: 30314561
[TBL] [Abstract][Full Text] [Related]
13. Is hysterectomy or prior reconstructive surgery associated with unsuccessful initial trial of pessary fitting in women with symptomatic pelvic organ prolapse?
Nemeth Z; Farkas N; Farkas B
Int Urogynecol J; 2017 May; 28(5):757-761. PubMed ID: 27796427
[TBL] [Abstract][Full Text] [Related]
14. A tailored flexible vaginal pessary treatment for pelvic organ prolapse in older women.
Gold RS; Baruch Y; Amir H; Gordon D; Groutz A
J Am Geriatr Soc; 2021 Sep; 69(9):2518-2523. PubMed ID: 33979457
[TBL] [Abstract][Full Text] [Related]
15. Symptomatic and anatomic improvement of pelvic organ prolapse in vaginal pessary users.
Mendes LC; Bezerra LRPS; Bilhar APM; Neto JAV; Vasconcelos CTM; Saboia DM; Karbage SAL
Int Urogynecol J; 2021 Apr; 32(4):1023-1029. PubMed ID: 33048180
[TBL] [Abstract][Full Text] [Related]
16. Effect of vaginal estrogen in postmenopausal women using vaginal pessary for pelvic organ prolapse treatment: a randomized controlled trial.
Chiengthong K; Ruanphoo P; Chatsuwan T; Bunyavejchevin S
Int Urogynecol J; 2022 Jul; 33(7):1833-1838. PubMed ID: 33991221
[TBL] [Abstract][Full Text] [Related]
17. Microbiome alterations in women with pelvic organ prolapse and after anatomical restorative interventions.
Kim M; Lee S; Kim HS; Kwon MY; Yoo J; Kim MJ
Sci Rep; 2023 Oct; 13(1):17547. PubMed ID: 37845312
[TBL] [Abstract][Full Text] [Related]
18. The effect of time interval of vaginal ring pessary replacement for pelvic organ prolapse on complications and patient satisfaction: A randomised controlled trial.
Tam MS; Lee VYT; Yu ELM; Wan RSF; Tang JSM; He JMY; Lui LKY; Chiu KP; Cheung RYK; Lee KW
Maturitas; 2019 Oct; 128():29-35. PubMed ID: 31561819
[TBL] [Abstract][Full Text] [Related]
19. Factors Affecting Successfulness of Vaginal Pessary Use for the Treatment of Pelvic Organ Prolapse.
Lekskulchai O; Wanichsetakul P
J Med Assoc Thai; 2015 Apr; 98 Suppl 3():S115-20. PubMed ID: 26387398
[TBL] [Abstract][Full Text] [Related]
20. Patient Satisfaction and Symptoms Improvement in Women Using a Vginal Pessary for The Treatment of Pelvic Organ Prolapse.
Radnia N; Hajhashemi M; Eftekhar T; Deldar M; Mohajeri T; Sohbati S; Ghanbari Z
J Med Life; 2019; 12(3):271-275. PubMed ID: 31666830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
